Tevogen Bio Holdings Stock Today
| TVGNW Stock | 0.05 0 2.39% |
Performance11 of 100
| Odds Of DistressOver 71
|
Tevogen Bio is selling for under 0.049 as of the 4th of December 2024; that is 2.39 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0432. Tevogen Bio has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. Tevogen Bio symbol was changed from LGSTW on 15th of February 2024. Equity ratings for Tevogen Bio Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of November 2024 and ending today, the 4th of December 2024. Click here to learn more.
IPO Date 3rd of January 2022 | Category Healthcare |
Tevogen Bio is entity of United States. It is traded as Stock on NASDAQ exchange. More on Tevogen Bio Holdings
Moving against Tevogen Stock
Tevogen Stock Highlights
| Older Symbol | LGSTW | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CEO CoFounder | MPH MD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tevogen Bio can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Tevogen Bio's financial leverage. It provides some insight into what part of Tevogen Bio's total assets is financed by creditors. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tevogen Bio Holdings (TVGNW) is traded on NASDAQ Exchange in USA. It is located in 15 Independence Boulevard, Warren, NJ, United States, 07059 and employs 12 people. Tevogen Bio Holdings was previously known as Semper Paratus Acquisition and was traded on NASDAQ Exchange under the symbol LGSTW. Tevogen Bio is listed under Pharmaceutical Products category by Fama And French industry classification. The company classifies itself under Healthcare sector and is part of Biotechnology industry.
Tevogen Bio generates negative cash flow from operations
Check Tevogen Bio Probability Of Bankruptcy
Tevogen Bio Historical Income Statement
Tevogen Stock Against Markets
Tevogen Bio Corporate Management
| Susan MBA | Independent Officer | Profile | |
| Mittul Mehta | Chief Tevogenai | Profile | |
| Sadiq Khan | Chief Officer | Profile | |
| Jeffrey MPH | Member Officer | Profile | |
| Tapan Shah | Head Development | Profile | |
| Kirti CPA | Chief Officer | Profile |
Additional Tools for Tevogen Stock Analysis
When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.